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Abstract 
Cortical  evoked  potentials  (EP)  provide
localized  data  regarding  brain  function  and
may offer prognostic information and insights
into  the  pathologic  mechanisms  of  malaria-
mediated cerebral injury. As part of a prospec-
tive cohort study, we obtained somatosensory
evoked  potentials  (SSEPs)  and  brainstem
auditory EPs (AEPs) within 24 hours of admis-
sion on 27 consecutive children admitted with
cerebral  malaria  (CM).  Children  underwent
follow-up for 12 months to determine if they
had any long term neurologic sequelae. EPs
were obtained in 27 pediatric CM admissions.
Two children died. Among survivors followed
an average of 514 days, 7/25 (28.0%) had at
least one adverse neurologic outcome. Only a
single  subject  had  absent  cortical  EPs  on
admission and this child had a good neurolog-
ic  outcome.  Among  pediatric  CM  survivors,
cortical EPs are generally intact and do not pre-
dict  adverse  neurologic  outcomes.  Further
study is needed to determine if alterations in
cortical EPs can be used to predict a fatal out-
come in CM.
Introduction
Cerebral malaria (CM) is a common cause
of  mortality  and  morbidity  among  children,
especially  in  those  younger  than  5  years.1-5
CM is traditionally defined as being unarous-
able coma in the presence of P. falciparum par-
asitemia with no other coma etiology evident.6
A CM-specific retinopathy has recently been
described  that  further  enhances  diagnostic
certainty.1,6-9 Of children with CM who reach
care, 15-25% die. Risk factors for death include
more profound coma, younger age, seizures,
hypoglycemia  and  hyperparasitaemia.10,11
Neurologic sequelae, including cortical blind-
ness, gross motor deficits, ataxia and language
regression  are  also  common  and  occur  in
~30% of survivors.11-12No prior studies of pedi-
atric CM have included evoked potentials (EP)
during  the  acute  coma.  Despite  extensive
research,  the  pathogenetic  mechanisms  of
CM-induced  coma,  CNS  injury,  and  death
remain  unclear.13 We  obtained  cortical  EPs,
specifically  somatosensory  evoked  potentials
(SSEPs)  and  auditory  evoked  potentials
(AEPs), in children with CM coma to deter-
mine if the presence or absence of cortical EPs
predicts adverse neurological outcomes.
EPs are the electrical responses to sensory
stimulation.  The  SSEPs  are  presynaptic  and
postsynaptic  responses  recorded  over  the
limbs, spine and scalp following the stimula-
tion of peripheral nerve trunks (median and/or
posterior tibial nerves). They provide a meas-
ure of sensory conduction and thereby detect
lesions in proximal peripheral nerves, spinal
cord, brainstem and the brain.14 AEPs consist
of auditory (click) stimuli delivered to each ear
following which responses are recorded in the
brainstem and cortex. They are mainly used for
evaluation of peripheral and central auditory
circuits in the brainstem. 
Cortical responses obtained on SSEPS and
AEPs have been widely used to prognosticate
neurological outcome and survival in patients
with coma due to hypoxic, anoxic, traumatic
and ischemic brain injury.15-18 The absence of
cortical responses of SSEPs and AEPs (in the
absence of peripheral nervous system or audi-
tory system dysfunction)  is indicative of irre-
versible cerebral damage and poor prognosis.15
EPs are obtained quickly and easily at the
bedside with inexpensive equipment, provide
information on brainstem function and could
be readily used in endemic areas if shown to
contribute usefully to the diagnosis, manage-
ment or prognosis in patients with CM. malar-
ia endemic regions, CT technology is the most
commonly available brain imaging option but
routine protocols provide very limited views of
brainstem anatomy due to bony artifact.19
Materials and Methods
From  January  to  June  2008  (the  malaria
season), children admitted to Queen Elizabeth
Central Hospital (QECH) with CM underwent
SSEPs and AEPs as part of their clinical assess-
ment.  Inclusion  criteria  for  this  study  were
admission  the  Pediatric  Research  Ward,  a
Blantyre  Coma  Score  (BCS)  of  <3,  P.  falci-
parum parasitemia, and the presence of CM
retinopathy identified by an ophthalmologist.
EPs were generally only available during day-
time  hours.  Children  who  died  or  regained
consciousness  before  EPs  could  be  obtained
were not eligible for inclusion in this analysis. 
AEPs and SSEPs were completed using an
XLTEK Neuromax 1004 System. AEPs were per-
formed by inserting small ear buds into the
external auditory canal for delivery of auditory
stimulus.  The  auditory  stimuli  consisted  of
clicks delivered at a rate of 10/sec at stimulus
intensity  of  60  dB  per  SPL  (decibels  peak
equivalent sound pressure level) and duration
of 0.1 microseconds. The contralateral ear was
masked with white noise. The responses were
recorded  between  the  vertex  and  ipsilateral
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stimulated independently and at least two sep-
arate trials were given consisting of 2000 stim-
uli that were amplified and averaged with band
pass filters at 100 and 3000Hz. The waveforms
were analyzed for the presence or absence of
waves III and V.14 SSEPs were obtained after
stimulation  of  the  median  and  tibial  nerves
bilaterally.  Median  nerves  were  stimulated
using a surface cathode 3 cm proximal to the
wrist crease and anode 2 cm distal to the cath-
ode.  The  electrical  stimulus  consisted  of
square-wave pulses at 7 per second. The inten-
sity of the stimulus was adjusted to produce a
visible  thumb  twitch.  The  responses  were
recorded at the elbow, Erb’s point (N9), over
the seventh cervical spine process (N13), and
the contralateral parietal cortex (N20) corre-
sponding to C3 or 4 of the 10-20 international
system.  A  common  reference  electrode  was
attached at Fz of the 10-20 system. The ground
electrode was placed on the arm. Each study
consisted of 500 trials averaged and filtered
with a band width of 30-3000 Hz. Similarly, tib-
ial SSEPs were obtained by placing the stimu-
lating  electrode  (cathode)  at  the  ankle
between the medial malleolus and Achilles ten-
don. The anode was place 3 cm distal to the
cathode and the ground was placed on the calf.
The stimulus intensity was adjusted to produce
a  small  plantar  flexion  of  the  toes.  The
responses were recorded at the T12 spinous
process (LP), C5 spinous process (N34), ipsi-
lateral cortex between C3 or C4 and P3 or P4 of
the 10-20 system (CPi) and midline between
Cz and Pz (CPz). A common reference elec-
trode was placed at the Fpz position of the 10-
20 system. The waveforms were recorded and
averaged  over  1000  trials  and  filtered  with
bandpass  of  30-3000  Hz.  The  presence  or
absence of cortical responses for the median
stimulation was based upon the N20 responses
and for the tibial stimulation it was based upon
the P37 responses.14
Survivors were followed up for at least 12
months  after  discharge,  to  assess  for  any
adverse neurological outcome. The discharg-
ing physician completed a neurologic exami-
nation  and  subsequent  assessments  were
completed at 1 month post discharge and quar-
terly thereafter by study nurses. These follow-
up  assessments  included  The  Epilepsy
Screening  Questionnaire  and  The  Ten
Questions.  The  Epilepsy  Screening
Questionnaire is a nine-item instrument that
has been previously used to screen for epilep-
sy in the developing world with 79.3% sensitiv-
ity and 92.9% specificity.20 The Ten Questions
instrument  has  been  shown  to  be  valid  for
identifying moderate neurodisabilities in chil-
dren as young as two years  with good reliabil-
ity  (kappa=0.67)  with  85%  sensitivity  for
detecting  moderate  to  severe  neurodevelop-
mental  disabilities.21 Both  instruments  were
forward and back translated into the local lan-
guage with discrepancy resolution prior to use.
Any child screening positive for potential prob-
lems by the nurses was seen by a neurologist
to confirm and characterize the nature of the
neurologic sequelae. 
This study was approved by the University of
Malawi College of Medicine Research Ethics
Committee  and  Michigan  State  University’s
Biomedical IRB. Written informed consent was
obtained  from  the  parent  or  guardian  of  all
children included in this study. 
Results
Twenty-seven children met inclusion crite-
ria  and  underwent  EP  studies  during  their
acute  admission.  The  study  population  was
characterized  by  a  mean  age  of  4.2  years
(median 2.7; IQR 2.3-5.8) and 13 were male
(48.1%). The average time from admission to
regaining a BCS ≥3 was 20.4 hours (median
10.5;  IQR  6.0-25.5).  Two  children  died  and
among survivors 7/25 (28.0%) had at least one
adverse neurologic outcome including epilepsy
(3 children), behavioral disorders (3 children)
and/or  gross  neurodisabilities  (4  children)
characterized  by  language  regression,  motor
or sensory deficits or ataxia.  Cortical respons-
es were present on EPs in 26 patients (96.3%),
including the two who later died. Only a single
subject had absent EPs during the acute CM
infection and this child had a good neurologic
outcome.
Discussion
The presence or absence of cortical respons-
es on SSEPs and AEPs during acute coma due
to CM does not predict long term neurologic
sequelae.  Some  limitations  to  this  study
include technical challenges such as the lack
of age specific normative data and documenta-
tion of limb temperature. More sophisticated
assessments including changes in absolute or
inter-peak  latencies  need  to  be  further
assessed. Neurodiagnostic staff were available
only during daytime hours, so we were not able
to assess some children, who recovered or died
before  EPs  could  be  obtained.  This  likely
excluded a higher than random proportion of
patients with fatal CM, which is reflected by
the fact that the mortality rate in our study was
7%  in  comparison  to  the  pediatric  research
ward’s overall rate of 16%. Further studies are
needed that include a greater number of CM
fatalities to determine whether EPs offer prog-
nostic information for survival.
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